<?xml version="1.0" encoding="UTF-8"?>
<sec id="Sec24" class="sec">
 <div class="title" xmlns="http://www.w3.org/1999/xhtml">Serum biochemical parameters</div>
 <p id="Par55" xmlns="http://www.w3.org/1999/xhtml">The results of biochemical indicators of liver and kidney function are summarized in Tables 
  <a rid="Tab3" ref-type="table" href="#Tab3">3</a>, 
  <a rid="Tab4" ref-type="table" href="#Tab4">4</a> and 
  <a rid="Tab5" ref-type="table" href="#Tab5">5</a>. The administration of CCl
  <sub>4</sub> caused severe hepato and reno-toxicity in the treated rats, as evidenced by the significant elevations of serum ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL urea and creatinine levels, while HDL level was decreased compared to control animals.
  <div id="Tab3" class="table-wrap">
   <span class="label">Table 3</span>
   <div class="caption">
    <p>Effects of CCl
     <sub>4</sub>, MpEO and their combination MpEO/CCl
     <sub>4</sub> on hepatic markers in serum of control and experimental rats
    </p>
   </div>
   <table frame="hsides" rules="groups">
    <thead>
     <tr>
      <th>Treatment and parameters</th>
      <th>AST (U/L)</th>
      <th>ALT (U/L)</th>
      <th>ALP (U/L)</th>
      <th>LDH (U/L)</th>
      <th>γ-GT (U/L)</th>
     </tr>
    </thead>
    <tbody>
     <tr>
      <td>Control</td>
      <td>164.82 ± 1.28</td>
      <td>65.88 ± 1.44</td>
      <td>149.61 ± 2.19</td>
      <td>20.81 ± 0.52</td>
      <td>3.17 ± 0.39</td>
     </tr>
     <tr>
      <td>CCl
       <sub>4</sub>
      </td>
      <td>524.12 ± 5.11
       <span class="sup">***</span>
      </td>
      <td>179.23 ± 3.39
       <span class="sup">***</span>
      </td>
      <td>217.47 ± 8.55
       <span class="sup">***</span>
      </td>
      <td>40.66 ± 0.81
       <span class="sup">***</span>
      </td>
      <td>5.43 ± 0.21
       <span class="sup">***</span>
      </td>
     </tr>
     <tr>
      <td>SL/CCl
       <sub>4</sub>
      </td>
      <td>191.15 ± 2.14
       <span class="sup">###</span>
      </td>
      <td>87.82 ± 7.61
       <span class="sup">###</span>
      </td>
      <td>157.50 ± 5.12
       <span class="sup">##</span>
      </td>
      <td>28.62 ± 0.62
       <span class="sup">###</span>
      </td>
      <td>3.47 ± 0.06
       <span class="sup">###</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">a</span>/CCl
       <sub>4</sub>
      </td>
      <td>479.89 ± 36.41</td>
      <td>162.02 ± 9.18</td>
      <td>202.42 ± 7.62</td>
      <td>37.75 ± 1.35</td>
      <td>4.45 ± 0.25</td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">b</span>/CCl
       <sub>4</sub>
      </td>
      <td>356.82 ± 35.77
       <span class="sup">##</span>
      </td>
      <td>147.35 ± 5.67
       <span class="sup">##</span>
      </td>
      <td>186.74 ± 3.98
       <span class="sup">#</span>
      </td>
      <td>34.16 ± 1.35
       <span class="sup">##</span>
      </td>
      <td>4.06 ± 0.17
       <span class="sup">##</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">c</span>/CCl
       <sub>4</sub>
      </td>
      <td>216.80 ± 7.26
       <span class="sup">###</span>
      </td>
      <td>97.82 ± 6.98
       <span class="sup">###</span>
      </td>
      <td>165.96 ± 5.12
       <span class="sup">###</span>
      </td>
      <td>31.64 ± 5.12
       <span class="sup">###</span>
      </td>
      <td>3.51 ± 0.20
       <span class="sup">###</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">c</span>
      </td>
      <td>160.80 ± 2.47</td>
      <td>63.08 ± 1.16</td>
      <td>139.77 ± 7.27</td>
      <td>19.89 ± 0.18</td>
      <td>2.81 ± 0.24</td>
     </tr>
    </tbody>
   </table>
   <div class="table-wrap-foot">
    <p>
     <span class="italic">AST</span> aspartate aminotransferase, 
     <span class="italic">ALT</span> alanine aminotransferase, 
     <span class="italic">ALP</span> alkaline phosphatase, 
     <span class="italic">LDH</span> lacatate dehydrogenase and 
     <span class="italic">γGT</span> gamma glutamyl transferase.
     <span class="sup">a</span>MpEO(5 mg/kg BW), 
     <span class="sup">b</span>MpEO(15 mg/kg BW), 
     <span class="sup">c</span>MpEO(40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
    </p>
    <p>Values are mean ± SEM for eight rats in each group. CCl
     <sub>4</sub>, MpEO and MpEO/CCl
     <sub>4</sub> treated groups vs control group; ** 
     <span class="italic">p</span> &lt; 0.01, *** 
     <span class="italic">p</span> &lt; 0.001, CCl
     <sub>4</sub> group vs MpEO/CCl
     <sub>4</sub> group; 
     <span class="sup">#</span>
     <span class="italic">p</span> &lt; 0.05, 
     <span class="sup"># #</span>
     <span class="italic">p</span> &lt; 0.01, 
     <span class="sup"># # #</span>
     <span class="italic">p</span> &lt; 0.001
    </p>
   </div>
  </div>
  <div id="Tab4" class="table-wrap">
   <span class="label">Table 4</span>
   <div class="caption">
    <p>Effects of CCl
     <sub>4</sub>,MpEO and their combination MpEO/CCl
     <sub>4</sub> on lipid profile in serum of control and experimental rats
    </p>
   </div>
   <table frame="hsides" rules="groups">
    <thead>
     <tr>
      <th>Treatment and parameters</th>
      <th>T-Cholesterol (mmol/l)</th>
      <th>T-Triglycerides (mmol/l)</th>
      <th>HDL (mmol/L)</th>
      <th>LDL (mmol/l)</th>
     </tr>
    </thead>
    <tbody>
     <tr>
      <td>Control</td>
      <td>1.133 ± 0.033</td>
      <td>0.736 ± 0.075</td>
      <td>1.413 ± 0.023</td>
      <td>0.123 ± 0.014</td>
     </tr>
     <tr>
      <td>CCl
       <sub>4</sub>
      </td>
      <td>1.750 ± 0.028
       <span class="sup">***</span>
      </td>
      <td>1.743 ± 0.078
       <span class="sup">***</span>
      </td>
      <td>0.446 ± 0.074
       <span class="sup">***</span>
      </td>
      <td>0.726 ± 0.053
       <span class="sup">***</span>
      </td>
     </tr>
     <tr>
      <td>SL/CCl
       <sub>4</sub>
      </td>
      <td>0.966 ± 0.033
       <span class="sup">###</span>
      </td>
      <td>1.043 ± 0.012
       <span class="sup">###</span>
      </td>
      <td>1.240 ± 0.030
       <span class="sup">###</span>
      </td>
      <td>0.176 ± 0.008
       <span class="sup">###</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">a</span>/CCl
       <sub>4</sub>
      </td>
      <td>1.606 ± 0.063</td>
      <td>1.610 ± 0.041</td>
      <td>0.690 ± 0.135</td>
      <td>0.640 ± 0.066</td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">b</span>/CCl
       <sub>4</sub>
      </td>
      <td>1.376 ± 0.076
       <span class="sup">##</span>
      </td>
      <td>1.196 ± 0.039
       <span class="sup">##</span>
      </td>
      <td>0.873 ± 0.053
       <span class="sup">##</span>
      </td>
      <td>0.253 ± 0.024
       <span class="sup">##</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">c</span>/CCl
       <sub>4</sub>
      </td>
      <td>1.033 ± 0.033
       <span class="sup">###</span>
      </td>
      <td>1.050 ± 0.010
       <span class="sup">###</span>
      </td>
      <td>1.296 ± 0.039
       <span class="sup">###</span>
      </td>
      <td>0.186 ± 0.017
       <span class="sup">###</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">c</span>
      </td>
      <td>1.100 ± 0.115</td>
      <td>0.763 ± 0.069</td>
      <td>1.210 ± 0.106</td>
      <td>0.113 ± 0.006</td>
     </tr>
    </tbody>
   </table>
   <div class="table-wrap-foot">
    <p>
     <span class="italic">TC</span> Total cholesterol (mmol/l), 
     <span class="italic">HDL</span> high density lipoprotein (mmol/l), 
     <span class="italic">TG</span> triglyceride (mmol/l) and 
     <span class="italic">LDL</span> low density lipoprotein (mmol/l). 
     <span class="sup">a</span>MpEO (5 mg/kg BW), 
     <span class="sup">b</span>MpEO (15 mg/kg BW), 
     <span class="sup">c</span>MpEO (40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
    </p>
    <p>Values are mean ± SEM for eight rats in each group. CCl4, MpEO and MpEO/CCl
     <sub>4</sub> treated groups vs control group; ** 
     <span class="italic">p</span> &lt; 0.01, *** 
     <span class="italic">p</span> &lt; 0.001, CCl
     <sub>4</sub> group vs MpEO/CCl
     <sub>4</sub> group; 
     <span class="sup">#</span>
     <span class="italic">p</span> &lt; 0.05, 
     <span class="sup"># #</span>
     <span class="italic">p</span> &lt; 0.01, 
     <span class="sup"># # #</span>
     <span class="italic">p</span> &lt; 0.001
    </p>
   </div>
  </div>
  <div id="Tab5" class="table-wrap">
   <span class="label">Table 5</span>
   <div class="caption">
    <p>Effects of CCl
     <sub>4</sub>, MpEO and their combination MpEO/CCl
     <sub>4</sub> on kidney markers in serum of control and experimental rats
    </p>
   </div>
   <table frame="hsides" rules="groups">
    <thead>
     <tr>
      <th>Treatment</th>
      <th>Urea
       <span class="break"/>(mmol/l)
      </th>
      <th>Creatinine
       <span class="break"/>(μmol /l)
      </th>
     </tr>
    </thead>
    <tbody>
     <tr>
      <td>Control</td>
      <td>7.53 ± 0.59</td>
      <td>11.12 ± 0.30</td>
     </tr>
     <tr>
      <td>CCl
       <sub>4</sub>
      </td>
      <td>15.41 ± 1.57**</td>
      <td>12.79 ± 0.15**</td>
     </tr>
     <tr>
      <td>SL/CCl
       <sub>4</sub>
      </td>
      <td>8.04 ± 0.32
       <span class="sup"># #</span>
      </td>
      <td>11.19 ± 0.27
       <span class="sup"># #</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">a</span>/CCl
       <sub>4</sub>
      </td>
      <td>12.52 ± 0.32</td>
      <td>11.94 ± 0.47</td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">b</span>/CCl
       <sub>4</sub>
      </td>
      <td>10.50 ± 0.29
       <span class="sup">#</span>
      </td>
      <td>11.45 ± 0.40
       <span class="sup">#</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">c</span>/CCl
       <sub>4</sub>
      </td>
      <td>9.44 ± 0.67
       <span class="sup"># #</span>
      </td>
      <td>11.39 ± 0.30
       <span class="sup"># #</span>
      </td>
     </tr>
     <tr>
      <td>MpEO
       <span class="sup">c</span>
      </td>
      <td>7.34 ± 0.38</td>
      <td>11.27 ± 0.35</td>
     </tr>
    </tbody>
   </table>
   <div class="table-wrap-foot">
    <p>
     <span class="sup">a</span>MpEO(5 mg/kg BW), 
     <span class="sup">b</span>MpEO(15 mg/kg BW), 
     <span class="sup">c</span>MpEO(40 mg/kg BW), SL: Silymarin (50 mg/kg BW)
    </p>
    <p>Values are mean ± SEM for ten rats in each group. CCl4, MpEO and MpEO/CCl
     <sub>4</sub> treated groups vs control group; ** 
     <span class="italic">p</span> &lt; 0.01, *** 
     <span class="italic">p</span> &lt; 0.001, CCl
     <sub>4</sub> group vs MpEO/CCl
     <sub>4</sub>group; 
     <span class="sup">#</span>
     <span class="italic">p</span> &lt; 0.05, 
     <span class="sup"># #</span>
     <span class="italic">p</span> &lt; 0.01, 
     <span class="sup"># # #</span>
     <span class="italic">p</span> &lt; 0.001
    </p>
   </div>
  </div>
 </p>
 <p id="Par56" xmlns="http://www.w3.org/1999/xhtml">Pretreatment with the MpEO at doses of 15 or 40 mg/kg significantly reduced levels of ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL urea and creatinine and increased the level of HDL compared to the CCl
  <sub>4</sub> group. It is worth noting that the treatment with 5 mg/kg MpEO did not induce any significant changes in the biochemical parameters (ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL, urea, creatinine or HDL) when compared to the CCl
  <sub>4</sub> group. Treatment of rats with only MpEO (40 mg/kg BW) did not result in significant alterations in biochemical parameters compared to control rats.
 </p>
 <p id="Par57" xmlns="http://www.w3.org/1999/xhtml">Pretreatment with silymarin (50 mg/kg), used as positive control, significantly decreased the elevated levels of ALT, AST, ALP, LDH, γGT, total cholesterol, triglycerides, LDL urea and creatinine and increased of HDL level as compared to CCl
  <sub>4</sub> group. Its effect was comparable in reducing of liver and kidney damage induced by CCl
  <sub>4</sub> with that observed for the highest dose of MpEO (40 mg/kg).
 </p>
</sec>
